Identifying and Measuring the Core Symptoms Reported by Persons with Asthma: A review of the Existing Qualitative Literature and Patient-Reported Outcome Measures
April 29, 2014-April 30, 2014 Fifth Annual Patient-Reported Outcome (PRO) Consortium Workshop Honoring the Past, Navigating the Present, Charting the Future April 29 – 30, 2014 Sheraton Silver Spring Hotel 8777 Georgia Ave
An Expanded Role for Patients in Clinical Trial Design – Podcast A discussion with Dr. Anne Rowzee of the Center for Drug Evaluation and Research, US FDA about patient input into the design of st
January 12, 2013 Patient-Reported Outcomes In Clinical Trials Of CKD-Related Therapies: Report Of A Symposium Sponsored By The National Kidney Foundation And The US Food And Drug Administration
April 11, 2013 Testing the Measurement Equivalence of Electronically Migrated Patient-Reported Outcome (PRO) Instruments: Challenges and Solutions
Assessing the translatability of a new patient-reported outcome measure for Major Depressive Disorder
Development of a New Patient-Reported Outcome (PRO) Measure for Depression: Progress and Results from the PRO Consortium
January 6, 2013 ePRO Systems Validation: Clearly Defining The Roles Of Clinical Trial Teams And ePRO System Providers
Qualitative Development and Cognitive Evaluation of the Symptoms of Major Depressive Disorder (S-MDD), A Consortium-Developed Patient Reported Outcome Measure